GL in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with GL today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Globe Life serves mainly lower-middle- and middle-income households in the United States. Policyholders pay its insurance subsidiaries premiums for basic protection. Life insurance supplies most premiums and insurance earnings, chiefly through traditional whole life and term policies. Supplemental health policies help cover gaps in existing coverage; Medicare Supplement pays certain costs that traditional Medicare leaves to patients.
American Income Life is its largest life-insurance sales channel, reaching working families through independent agents who sell exclusively for Globe Life. The company also sells directly to consumers. Keeping productive agents and persuading policyholders to maintain coverage are important to the business. Profitability depends on claims and expenses staying within the assumptions used to set premiums.
The insurers invest premium receipts not needed for current expenses mainly in long-term bonds to fund future benefits. Investment earnings above the amounts needed to support policy obligations add to profit. State regulators oversee insurance pricing and operations, and Medicare Supplement premium increases require regulatory approval. Globe Life itself is a holding company: it relies heavily on cash from its insurance subsidiaries, whose payments to the parent are constrained by regulatory capital, solvency and dividend limits.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Globe Life’s results hinge chiefly on household demand for basic life protection and claims experience, with privately held Mutual of Omaha another important rival to watch in direct-marketed life and Medicare Supplement insurance.
CNO Financial Group competes directly with Globe Life for customers buying life insurance through direct marketing, and also sells Medicare Supplement and supplemental health coverage through workplaces. Watch its direct-marketed life business for competition facing Globe Life’s sales to lower-middle- and middle-income Americans.
Primerica and Globe Life compete for middle-income families buying basic life protection through large agent networks, but Primerica emphasizes term insurance rather than whole life. It is a comparison for Globe Life’s agent-led family protection business, not a matching product mix.
Aflac competes with Globe Life in U.S. accident, cancer and critical-illness coverage, selling supplemental insurance that pays cash for eligible claims to help cover expenses primary insurance leaves unpaid. Watch Aflac’s U.S. supplemental-health business rather than its substantial Japanese operations when assessing competition for Globe Life.
Unum Group, particularly Colonial Life, competes with Globe Life for life, accident and critical-illness protection sold to people through their workplaces. Watch Colonial Life’s premium income for the part of Unum most relevant to Globe Life’s workplace sales.
Aegon’s Transamerica business competes with Globe Life for U.S. families buying life protection through agents, including the World Financial Group network. That agent-distributed family life business is the relevant comparison for Globe Life, rather than Aegon’s broader retirement and asset-management businesses.
Globe Life Inc. earningsThis company
Globe Life's report will show whether premiums from its life and supplemental health policies are growing enough to cover claims and sales costs and lift underwriting margins.
Read life and health premium growth alongside each line's underwriting margin—the premium left after policy obligations, acquisition costs and commissions. If premiums grow and margins hold or widen, new business and pricing are covering claims and selling costs; slower premiums or narrowing margins show weaker growth or more of each premium being absorbed by claims and costs. Also check excess investment income, the investment income left after interest required for policy liabilities: a decline means less support from investments. Together, these figures show whether premium growth is turning into profit.
Fed Interest Rate Decision
Globe Life earns profit when investment income on its insurance portfolio exceeds the amounts needed for policy reserves, so the Fed’s rate decision matters through returns on investments and the cost of keeping policies in force.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher rates can lift returns as Globe Life invests cash and premiums in new assets, supporting excess investment income; but some life policyholders may surrender coverage, reducing premiums and future investment funds.
If it comes in below expectations
Lower rates can reduce returns on new investments, making it harder for Globe Life’s portfolio to earn more than policy reserves require and potentially squeezing insurance profit, even as cheaper borrowing may ease financing costs.
PRIMERICA, INC. earningsPRI
Primerica's report will show how demand for its agent-sold term life insurance among middle-income families is changing, offering a comparison for Globe Life's agent-led family life business.
Compare Primerica's term-life sales with life net sales and first-year collected premium in Globe Life's American Income channel. If Primerica strengthens while Globe Life's related new business weakens, competition for middle-income families through agents may be intensifying; if Globe Life strengthens while Primerica weakens, Globe Life's agent channel appears more resilient. Their products differ, so the gap does not prove a market-share shift; the takeaway is whether Globe Life's agent-led sales are holding up against a relevant competitor.